Vinny Hayreh, MD
Immuneering Corporation · Bristol-Myers Squibb Research and Development
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Vinny Hayreh, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:43 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06208124 · A Study of IMM-6-415 in RAS/RAF Mutant Solid TumorsImmuneering Corporation · completed · Advanced Solid Tumor (Phase 1), Pancreas Adenocarcinoma, Non-small Cell Lung Cancer · study director
- Ph1/Ph2NCT05585320 · A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsImmuneering Corporation · active not recruiting · Advanced Solid Tumor, Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) · study director
- Ph3NCT03342352 · Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)Incyte Corporation · withdrawn · Head and Neck Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.